Invention Grant
- Patent Title: Morpholine derivatives as norepinephrine reuptake inhibitors
- Patent Title (中): 吗啉衍生物作为去甲肾上腺素再摄取抑制剂
-
Application No.: US10577841Application Date: 2004-10-28
-
Publication No.: US07423037B2Publication Date: 2008-09-09
- Inventor: Gordon Iain Campbell , Manuel Javier Cases-Thomas , Teresa Man , John Joseph Masters , Hélène Catherine Eugénie Rudyk , Magnus Wilhelm Walter
- Applicant: Gordon Iain Campbell , Manuel Javier Cases-Thomas , Teresa Man , John Joseph Masters , Hélène Catherine Eugénie Rudyk , Magnus Wilhelm Walter
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Thomas E. Jackson; Charles E. Cohen
- Priority: GB0326148.4 20031110
- International Application: PCT/US2004/032771 WO 20041028
- International Announcement: WO2005/047272 WO 20050526
- Main IPC: A61K31/535
- IPC: A61K31/535 ; C07D413/06
Abstract:
Compounds of the general formula (I) are inhibitors of the reuptake of norepinephrine. As such, they may be useful for the treatment of disorders of the central and/or peripheral nervous system.
Public/Granted literature
- US20070083046A1 Morpholine derivatives as norepinephrine reuptake inhibitors Public/Granted day:2007-04-12
Information query
